Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 14.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000164 | Am Alaqeel [Canada, Arabie saoudite] ; H. Abou Al-Shaar [Arabie saoudite] ; Rk Shariff [Arabie saoudite] ; A. Albakr [Arabie saoudite] | The role of RNA metabolism in neurological diseases |
| 000187 | Gerald W. Zamponi [Canada] | Targeting voltage-gated calcium channels in neurological and psychiatric diseases. |
| 000203 | Moonhee Lee ; Edith G. Mcgeer ; Patrick L. Mcgeer | Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases |
| 000493 | Marcus W. Koch [Canada] ; Lawrence Korngut [Canada] ; David G. Patry [Canada] ; Yahya Agha-Khani [Canada] ; Christopher White [Canada] ; Justyna R. Sarna [Canada] ; Michael Yeung [Canada] ; V Wee Yong [Canada] ; Daniel Y C. Heng [Canada] ; Gary Cutter [États-Unis] ; Luanne Metz [Canada] | The promise of futility trials in neurological diseases. |
| 000939 | Michael D. Fox ; Randy L. Buckner ; Hesheng Liu ; M. Mallar Chakravarty [Canada] ; Andres M. Lozano [Canada] ; Alvaro Pascual-Leone | Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases |
| 000A19 | Lindsey B. Gano ; Manisha Patel ; Jong M. Rho [Canada] | Ketogenic diets, mitochondria, and neurological diseases |
| 000E09 | Bo-Rim Yi [Corée du Sud] ; Seung U. Kim [Canada, Corée du Sud] ; Kyung-Chul Choi [Corée du Sud] | Development and application of neural stem cells for treating various human neurological diseases in animal models |
| 001F53 | Seung U. Kim [Canada, Corée du Sud] ; Jean De Vellis [États-Unis] | Stem cell‐based cell therapy in neurological diseases: A review |
| 002B35 | Thomas E. Marler [États-Unis] ; Vivian Lee [Canada] ; Christopher A. Shaw [Canada] | Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins |
| 003A16 | E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | The future use of complement inhibitors for the treatment of neurological diseases |
| 004301 | O. Yasuhara [Canada] ; T. Kawamata ; Y. Aimi ; E. G. Mcgeer ; P. L. Mcgeer | Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases |
| 004450 | A. Beuter [Canada] ; J. Belair ; C. Labrie | Feedback and delays in neurological diseases: a modeling study using dynamical systems |
| 004659 | E. G. Mcgeer [Canada] ; E. A. Singh | Angiotensin-converting enzyme in cortisal tissue in Alzheimer's and some other neurological diseases |
| 004B30 | R. J. Uitti ; A. H. Rajput ; B. Rozdilsky ; M. Bickis ; T. Wollin ; W. K. Yuen | Regional metal concentrations in Parkinson1s disease, other chronic neurological diseases, and control brains |
| This area was generated with Dilib version V0.6.29. |  |